{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert, Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
      "version": "1.0.1"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/schweig2017.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "872b658bd05e999c26fd3eeb76c72a1a0b4a2db85ccfea81b75155d7ec37b28194b1717c63796e1c53efa81694b9914427f9c7f60e8f58a64546462ad8933a2c",
      "line": 91,
      "relation": "increases",
      "source": 23,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "7cc8cbc096139cbc8055ad4e2e443871ebdf405ca24ac7d8c74010f42e0eec0a8a8356a8b90edc1459075f8526b31d202a7fc424194315f64ef9d9cc5966d8b8",
      "line": 92,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "75770d3d03d82774e9f2fe0b6548a997179961f38d0028f35a567b37cf72314dd3a939d99241c22a9eb356174f8fce1169971d7a40aea1bbf5aadb4aace1fca9",
      "line": 93,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "008816f23520cd15f3d66801f477542d5df1ec119f602a265caa27f6bfc70d78e110a0f3ec81fadf9debfa2107a659372298790da45e95316aa3e84bee1bda55",
      "line": 92,
      "relation": "positiveCorrelation",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "key": "25787833614cfbe41dd75099b08d1d53a8a0e2ec882887079d382b1a44a52f19d8dc05268929232a3f110cf384aa18b1a6375c366950bb8cd48400cbb8bb71bc",
      "relation": "hasVariant",
      "source": 19,
      "target": 20
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A Î² deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "1e95bfeb90a93fbe16ffe12e9e645dd815c78beb448c3b69d573de7ffc35ecf047629dfadba3ad6404a61ace5dcb2c7aa834b0ed75342b43a6d8f510a7f55804",
      "line": 115,
      "relation": "positiveCorrelation",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A Î² deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "4bb4c449ecc8afbbfb858416f851a83c53071fd07cfda5261a2783c3b1873f149f590c2f82e2cb5ca70662be9c04f74ee773daae7e1d5fbee7131e66db5b2918",
      "line": 116,
      "relation": "positiveCorrelation",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "key": "49e16efe304bb1eea3516d14e47c6ef4e8d3acfbd4c7edf3318941395999adc8bbc6c0b2739fd02809b0418008fb3550faf2b2707cfe749b809cf6150447b7aa",
      "relation": "hasVariant",
      "source": 19,
      "target": 21
    },
    {
      "key": "ad3ad9f758f4d7972e1ad8c6afbedc2d838ae5fb7dcf5cd5dc1c75215c1c642d8e136566b2ffac97eb5d48c6fc0826c2a3761182402abec2e55a3b8c57aff84d",
      "relation": "hasVariant",
      "source": 19,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "d429dedce14cdb2339041a1224a85dec1b8f6f5a7daa922c16eeb3e68a64bc468e8c73e243afcfca9d41e68fdedbb706bc2a2539af5d09f3508389b50b038055",
      "line": 93,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In addition, we observed that pSyk immunoreactivity is upregulated near A Î² plaques but neither colocalizes with microglia nor astrocytes suggesting that it could be of neuronal origin. (Fig. 1e). ",
      "key": "7c37a97c0b77155291d7d832cf3ce6e4c5b7b02e95c1f9d31800f8511a48dd8990c39abbde9cec2008caa5df6a2639f8c4e4b09aef0caeb5d42af20b9d1bf02f",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In addition, we observed that pSyk immunoreactivity is upregulated near A Î² plaques but neither colocalizes with microglia nor astrocytes suggesting that it could be of neuronal origin. (Fig. 1e). ",
      "key": "f4093cb8326a20aa8c3dc0030cca2f70f08b0591c21ef0461107a270cb25b3320d1afb4a801ca91a0c474473aed9638be08b6b4f3c8d672842f8981c6a504502",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 20
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A Î² deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "04ebfba70ce51062b47746007310d207fbb0661ad04fe53f79ae8293c07d4f26060a711a7577a26fe52ccce3e01f18f7dc62e02ad9f3283d28f91b1eadbe863e",
      "line": 115,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 19
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "9a52a4ec6e882d9e409b5fe167160c29f66cfb4631e748804a534008d1f7d6103e0a9c422789d629e0543bf904c658832c7388bf6b45abfd69bcd08df1ceb11b",
      "line": 311,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 13
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A Î² deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "98bcd08b5b349e7b348ac4413b2953f9cf81987f496413c41323dd4b97f5e9d95e725fc4e7b1ca743a5df3f8d7e4a72fb9bb7084c69d0fd70e1e1eb0951978ad",
      "line": 116,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 19
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Dystrophic neurites are characterized by an accumula- tion of BACE-1 and sAPP Î² [31] and our previous work [28] has shown that Syk regulates BACE-1 expression and sAPP Î² levels suggesting that Syk upregulation in dystrophic neurites could contribute to the accumulation of BACE-1 and sAPP Î² .",
      "key": "99995dc2b720b237d3387997cb8d8b9f1f2484b60d5f250f326ecec0e380921e9d0e1cbd92bf962833e82abe8a5efc52fb80844e3bc2867a4fce0c78f16d949b",
      "line": 131,
      "relation": "regulates",
      "source": 13,
      "target": 6
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Dystrophic neurites are characterized by an accumula- tion of BACE-1 and sAPP Î² [31] and our previous work [28] has shown that Syk regulates BACE-1 expression and sAPP Î² levels suggesting that Syk upregulation in dystrophic neurites could contribute to the accumulation of BACE-1 and sAPP Î² .",
      "key": "ee0779b0008be988351c8fb84b34bf31c4f4c764eabb45954cc7c6c3f33f97e1685057856e6ce4a92ae31fda113f2c51bf607c8f993f8ad5b33dbf367f3de55c",
      "line": 132,
      "relation": "regulates",
      "source": 13,
      "target": 5
    },
    {
      "key": "0e7b434f72b721fce057e792c53e5c7688b5c3562da70f57b6d2c61f5979ac36a5d0186410bb0ddeba84b4a2bac946684c8f2cedac625558debb3688b7b2dcf1",
      "relation": "hasVariant",
      "source": 13,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "917efafbba6cce1c72adf3b6533df2e89053a0e00218850743fd4cc96873b0e0f4b380f5afd689935af4e8b1b4c820bf6cba144924a0b884842d2bfe5e244c67",
      "line": 245,
      "relation": "directlyIncreases",
      "source": 13,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "456481bb87080b3d93b2f81cfec786de54263a2998e5d96509b2e34280819fe6e259763ed0b6fb4d46e425147eabfc5f57ab49b780f6fbde5e04fe9fe0f38f29",
      "line": 263,
      "relation": "directlyIncreases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Interestingly, Syk up- regulation in SH-SY5Y cells leads to a significant in- crease (1.7-fold) in phosphorylated tau at Y18 (Fig. 14c, p < 0.01) and at S396/404 (Fig. 14d, 3-fold, p < 0.0001) compared to control cells.",
      "key": "7173300b2eb40142f6d8efbb2cc1bab2317547f4ee4d5f7cbafb7b0ac93872b9eba253dfde712ce3b5ae36cfdb614987d1e013b5d571657165c3fc26ab84c764",
      "line": 276,
      "relation": "increases",
      "source": 13,
      "target": 12
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "4490de37969e6d69d386aa3ae8443b10967f5a2a8b11a20897971ed6adc727f221c2e0111b0ee48b6a85a1011490b4219ab4677eb3438a47a16090ee52534e4a",
      "line": 312,
      "relation": "positiveCorrelation",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We have previously shown that Syk positively regulates GSK-3 Î² activity in vitro.",
      "key": "460de9959d7de30f7b718c168c7ddc402f64a3bf9c2c3a6f670e9cbbcf391052f796c025ca8149106842494665654619cca1c773b87af8f565733c2239add763",
      "line": 252,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 13,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "5bac1664b48611562a0a26b251b7ea2e089be484f4a9890b165826166bf434cd4e9afef6b50d82b57f024e376521b0ef8962454fb6016749135956fccde7fd92",
      "line": 264,
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Interestingly, Syk up- regulation in SH-SY5Y cells leads to a significant in- crease (1.7-fold) in phosphorylated tau at Y18 (Fig. 14c, p < 0.01) and at S396/404 (Fig. 14d, 3-fold, p < 0.0001) compared to control cells.",
      "key": "31fc909f7abf86970d1404a1e8b53898acb32e3a18829c953a86f8707ea0f5c235e4b9bc557e83efb06a341bfb47920bd67788eaaa635ed73f9f12b01f4b7ade",
      "line": 277,
      "relation": "increases",
      "source": 13,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "7434b45e70c90ec94b4e89e6c111aaeccc95d4c957295d2e9f4c1ef975d65a77451c0736624711f2cdbca57de086446f4260406f32d2020d209586c314923b44",
      "line": 265,
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "344930ee0a9d996c3b22706d6940423e64b637a351307a81b04ce3eec246f57c0cb5950aabcfdda9606bde32c05c9b06df9d4e4042bfb4a34cc1b53bda4bc1c4",
      "line": 266,
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "47c390d03872bec85474d535bac3ef3b8c5295b366cf430de2fa821f2b96f346a34b050877df68ae964a3ded8faab8cef692c7565ed337aea1495e31f2f4a32d",
      "line": 313,
      "relation": "positiveCorrelation",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Total tau levels are also sig- nificantly increased following Syk overexpression (Fig. 14e, 4.2-fold, p < 0.0001). ",
      "key": "4c4ffd004136d58c6b1ac2b68691704ac337922e214eb44494975759de50d77b1be904a94f4060eb0fb512882935d6b6d53114582b60ef6f66c5ba160eb867b7",
      "line": 285,
      "relation": "increases",
      "source": 13,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "We analyzed the possible impact of Syk overexpression on Tau mRNA levels by quantitative RT-PCR and found that Syk overexpression does not affect Tau transcription (data not shown) sug- gesting that Syk may regulate tau degradation or tau protein translation.",
      "key": "728ac0a4360e913c194331e25467850362bd0a2aa77ce984d115da930e1da55c7a1f6b04e28fea74bab9ed699e4ad50f5888537bc6708d5b2229ea5afbc92be8",
      "line": 296,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "regulates",
      "source": 13,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "We analyzed the possible impact of Syk overexpression on Tau mRNA levels by quantitative RT-PCR and found that Syk overexpression does not affect Tau transcription (data not shown) sug- gesting that Syk may regulate tau degradation or tau protein translation.",
      "key": "d46b64d9ff5253a3e2c9012105c959455b7ac955b75c1f59331df7b1dc3392128ac8dbea0f5a47c2ee1a15591ae57918eb38f7a966bbc9a321d7b54916fe37aa",
      "line": 295,
      "relation": "causesNoChange",
      "source": 13,
      "target": 24
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "83b1d74196a6b22ace5ab845cd3e5f066b0d635b5b1a931d79d7da520c0bb0c3737b761140a7a008d06d40f25c603a09295daeccf018c65739e88f046dc75bd9",
      "line": 311,
      "relation": "positiveCorrelation",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In contrast, microscopic fields of older Tg APPsw mice containing A Î² deposits exhibit a strong increase in pSyk burden (799.95 Â± 130.19%) com- pared to age-matched WT mice. ",
      "key": "4bb319f56eea4f3bae481dc0a6d5959a89b49ac5a3a8767b4a4a01f191326526533993d58e563b393d7edd67587c1c45feafcd8cefe8c1c7744eb1d0ddfb7024",
      "line": 145,
      "relation": "increases",
      "source": 4,
      "target": 20
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also show an in- crease in tau hyperphosphorylation and pSyk with age (Fig. 7). ",
      "key": "76ff1a340fb2e24282b08adce9ee48d4b0a9d28cb280c5d6fc77d2d0a6e5d3296a6c21c502e9c9f939de4b6309c95524af4266e1ab360f354788eeab18bb70c8",
      "line": 220,
      "relation": "increases",
      "source": 4,
      "target": 20
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also show an in- crease in tau hyperphosphorylation and pSyk with age (Fig. 7). ",
      "key": "bf4d6fbc0f7ea0496955b336f25f5ccb6f1ddb0f1e1fed64f36f3262bfebce10e5a931a90bc2ea07f6149130a976a76351ddce886c4d19fcf504eda0b17a7975",
      "line": 218,
      "relation": "increases",
      "source": 4,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also show an in- crease in tau hyperphosphorylation and pSyk with age (Fig. 7). ",
      "key": "95de243607e4c28c9fa7048b5d3619e207402551072e1f08e3bd60cefdeea2f09ec18aaadfb66ea5c8db33b64da8093255eb74ee621c70971a5da7aa9b3e3772",
      "line": 219,
      "relation": "increases",
      "source": 4,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Hippocampal neurons of Tg Tau P301S mice exhibit a high level of tau hyperphosphorylation (Fig. 4b) as well as an accumulation of pathogenic tau conformers (MC1, not shown) compared to WT littermates (Fig. 4a).",
      "key": "15f63dd2434d9688b9483d3c8acb8cf46e2814be191827046847cadbb8efb5329ab43ceab71af6d1dacf121e2141b37e15f24eebf8f108910569033c1e3c97b6",
      "line": 158,
      "relation": "increases",
      "source": 18,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also exhibit an increased level of tau hyperphosphorylation (Fig. 5b) compared to wild-type littermates (Fig. 5a).",
      "key": "0ebc0505f483ea2df24a42d9386bd6ddc513c29756e8d97732aabd7eb234d1c6dcc50450bb48e0a0351ec922878fb740352c13864bb0e588ed51891bd007206b",
      "line": 182,
      "relation": "increases",
      "source": 18,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Hippocampal neurons of Tg Tau P301S mice exhibit a high level of tau hyperphosphorylation (Fig. 4b) as well as an accumulation of pathogenic tau conformers (MC1, not shown) compared to WT littermates (Fig. 4a).",
      "key": "6a682a754b2befef3b9d4b60730a7cda3499d519cc83d1eb8bff2a3876885bebfeda35e4d8c8ad423fe478fc2847d74f5a8aed8151f27e3c3d493316ce7a8aec",
      "line": 159,
      "relation": "increases",
      "source": 18,
      "target": 0
    },
    {
      "key": "a555485af499c9e6722d077cabb13f2c5c94256e445c59eeb80ea82e018a504b3043b21978c38c6437dfaa85f05e2d2cf8ac1897538a8d54d0ab99ce0c35e74f",
      "relation": "hasVariant",
      "source": 15,
      "target": 18
    },
    {
      "key": "1fa1b65dc3e5e4831d66c47e17e6e8ac502d1d2517c5f3b2c62ea024b006f644253de493a20a8ee8649cbff19f13edfa9d7df2797000296915dce340ed72ed50",
      "relation": "hasVariant",
      "source": 15,
      "target": 16
    },
    {
      "key": "1706b00f5d063ca5b2926c3a8d0c054d2888343cd9432a91a19f20810c939bc2e48ff513189d7ff5298ca72d123f9779ee78e045f3cc68f1f1923af987437177",
      "relation": "hasVariant",
      "source": 15,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "05afa2558a5754b1081f85903c27fec6ecd4650fdba0fee200d4ab057961147a3f188418b11f3a93793370645f5c252ef20d55655a5ddc505204f9dba9e822a6",
      "line": 206,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 16,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "11b3b42b74777f459a4158e17ad7f272de802bc81759f43bfb3e3d3c0092dc4b8d70c19c1a81bc0d00f1ab88d6ef55c11076b76e9679be99727bf08c723476e0",
      "line": 207,
      "relation": "increases",
      "source": 16,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "196316eaaffdeea13581eaf3e565598de849dc4d09e94ece9942ad143530ff608b1d5dc176a168de262163fd1fb79e946810c32081ab1c9a5a0b2929ef0af90a",
      "line": 169,
      "relation": "association",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "3b0235fcbf4252f9532881bc6fad57e9e033a166f1a5f0a55ea6a4ffb95f5057fe00ea616237236cfe0ef35405676628d0f1861b43a6cf515fc3964bd3608f58",
      "line": 170,
      "relation": "association",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "b4967559cfb25f4e565ab9d5386f22f5c5f8e490c47c2c350fee4922eed2c3496c3b9cb1045be937b9f49c261d3a23bdcc79316e12152edaf9ba49fe3bfa60d4",
      "line": 192,
      "relation": "association",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " In general, we found that neurons that exhibit a high level of pSyk immunoreactivity also demonstrate a higher level of tau pathogenic species whereas neurons that are weakly immunopositive for pSyk show less tau pathology (Figs. 9, 10, 11, 12 and 13).",
      "key": "dbbec71b5e8807140c9d05361aef5000be44169762839e13f005c0dca11c84c8dbc533f8f3522cfcc0efe6a16c74e6994bdb8658645abdcdd65e747725905926",
      "line": 232,
      "relation": "positiveCorrelation",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "bf41683b956ae969cd6974601a00f0a7d9dc70db2d57ca2b9ec24b30feb94ad568bb154cf10299bba6c2a42a8c601a3ac08774bce1b594dea2a0222fef8da93f",
      "line": 169,
      "relation": "association",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "3662a8858dd4c8c38e2429cc253f947eec289e5a10a25627f3f8c2e0e94eaf9292df993f4fd8a2587612b53edc04567987ad251ef155e8aec5f50cbf586f3a05",
      "line": 170,
      "relation": "association",
      "source": 22,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "516bef4aa2c336abc62cf4b135480c46afb08ff1a44179da73b87af287aadbe8a386778449e2296779cfd72ffd8a7dc4a091e80fe035de0cb27feba072f624fe",
      "line": 192,
      "relation": "association",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " In general, we found that neurons that exhibit a high level of pSyk immunoreactivity also demonstrate a higher level of tau pathogenic species whereas neurons that are weakly immunopositive for pSyk show less tau pathology (Figs. 9, 10, 11, 12 and 13).",
      "key": "a02093fe8f2ae384820da9f6babd85d92cbfa921506d8626115a3f9ae1f532d471816cc303bc0828e62e03e8200008f2bad976f05bf8e2f5396d8392ef7d03a9",
      "line": 232,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "af61a817d78e1a8ba7928b5ab987a124cfe02708b5185d59623746027974940a2d33f2d3de661b618781ee9671b5ce8d7b7c14e9d66f11dffa3582163cbec515",
      "line": 193,
      "relation": "association",
      "source": 14,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "ec51954907a7e2a42e92c58fcb836c2a1f55b531c5b21d1b2939116bcc2c7ea1e6700c8ee03dd47840e487283192d3cae738a1865f218fc6a8784a8b28bdd48c",
      "line": 243,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 12
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "09bf5edfa768d32e3615696808db6a5c021c501850e3da2cf5b70158b09d9911e301fd732c00c6e78a220dc7380a74776987497b6f05dcf17685db9f1e079b03",
      "line": 193,
      "relation": "association",
      "source": 17,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "b972e5b2f68b61b28a09dbab130a457d60a20b679e72f3fd5a6846f724e97326389382f9f1a4cd3d38e1222d3433145f88bcd85d1362cfcd637c8724ea18b9f2",
      "line": 243,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "38fc59b21e08f8ec22559e5dba39d006d65a4595aaed737ba5a76be6d5d9966710c2d8296829c830717b0438e937490fb55213f4835f07addb0cbb6e89a3afdd",
      "line": 262,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 12,
      "target": 13
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "695a07776a2368aab89f0ddb2a0e6a38955325bc3296cd8c22a7140af434f0560c6de5a3707750b4e36c17c82b7ca140f08af8cc16c9308992e0e7d0a64fc30b",
      "line": 312,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 13
    },
    {
      "key": "9cfb692e3b39903e05776d10e5ec184405b65b7ee2afbee7a958ac60be2e0a8de0d684efe5a7fcc4198d4d76591b906798952e7cda8584eb982d9758803184ed",
      "relation": "hasVariant",
      "source": 8,
      "target": 12
    },
    {
      "key": "0efa2343a1aab409feeae95a44c4251f713383a6e606f151efb4055e8f77a89d772738244ac3792bc5938f0fe885967c3489d8612cccddfd37a4a5dd7ed7c968",
      "relation": "hasVariant",
      "source": 8,
      "target": 11
    },
    {
      "key": "57f6dfc4cb18d002fb185a5f8ddb26897f5c0e93f59d9f1ee55374a026a04da6c975e40dd70e3f890ef9f9793c8b77bf916ea47533ecfee045a95797915ad8ba",
      "relation": "hasVariant",
      "source": 8,
      "target": 10
    },
    {
      "key": "13a2d85350646bfafba125050fe61a93ae30be74c95d0b86603c3c3006a7c6909c935b1c78e5a1d55453d657170985535cd8b87bfecfcd7f077c3b43173e71aa",
      "relation": "hasVariant",
      "source": 8,
      "target": 9
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A Î² deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "930e7345a61882f153991bb276d67323624b31d716cd47f48128743cf54db3d72af1f6c1984ea2c05b09e28d97675b726142e737dd3a695a61048770e76e1c68",
      "line": 313,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 13
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "102bd40eb29c18f3cd2b3c48aa1a96afad05e01e0f8090172738d382dcfa933ac25a510484a34dd66c94587194ad5f9d99148b59a7741edc83871b3edf50ed4e",
      "name": "Tau aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "function": "Abundance",
      "id": "fcc150a975d4e4470c5e429ea32220fdb47e51ef258188552e58fa57f7095a6257914f165d06469ed45b6a1bccc8149eacc0ad9fdf9248a2ac69db715285c72a",
      "name": "amyloid-beta aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(MESH:Neurites)",
      "function": "Abundance",
      "id": "168fd5376eaf2b44233d03b4eccab5577851dff906b9e2e5356afc88956c540c5275adc2535998d7a27e6166a7e9a17e606ecc799f2276d238b5fa11a3e6efea",
      "name": "Neurites",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "function": "BiologicalProcess",
      "id": "9e9682b78aa06bbcb9dae35006f6da468e11928c000097001cd665b1bedf3c75ef887ecd7781ef3c545cafb3780cb7afabec9bfc70e14a48149d8adee8502981",
      "name": "microglial cell activation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:aging)",
      "function": "BiologicalProcess",
      "id": "e656a7a9b8877eca28efc8bcece0149b9f17b643e48c2ae605fb3977fb925968220ed9a29a1649919bd2bdbfd43e6cd082182ead002a6eb840cd3f1e4f57d213",
      "name": "aging",
      "namespace": "GO"
    },
    {
      "bel": "p(CONSO:\"sAPP-beta\")",
      "function": "Protein",
      "id": "5398d4984129759e9b240bafa6b1c68a4fa29a53cd3b11c8c3e9a0cf7ed4ad658837071ea10d874d9f67aa0a38eda520f01d74ce3462dcdcad62c2669f34828d",
      "name": "sAPP-beta",
      "namespace": "CONSO"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "function": "Protein",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c",
      "name": "GSK3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:misfolded))",
      "function": "Protein",
      "id": "f4a178c5252fa2a4484fe4e3d8e266a626ded68a01d10c4ddf420e5f956374515e858574724068a0005fa79250fd4997a9b3906b824f4581f44daee0c6e1b718",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "misfolded",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 202))",
      "function": "Protein",
      "id": "49b56446b699c749fbb01c4560254bbf621f44bd52a02cb74e212fb0ef1b9b1616a31cfe6ca06023fee3689ef552a3e8fe71211987ebad4180c2d78535f4ad7a",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 404))",
      "function": "Protein",
      "id": "39bce9d17a0e3ef84038e06e52460d0a74f6adb7a3bffaba4858b8ada9ad6cc683cfaf93b6bb11e329e2818937b3cb05c7bb618018d5bf2b718fbfcadcd03af5",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        },
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 18))",
      "function": "Protein",
      "id": "5b045c071b780caaf6d0a4441b95389b9857364de91d6676af9d7497e2f4fd2ceda3e2ac4bb7f5e526690284a133fa5fce968527f72d8e1582029f1551a0c7bc",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 18
        }
      ]
    },
    {
      "bel": "p(HGNC:SYK)",
      "function": "Protein",
      "id": "b0e9f727ba248d29d2019ec99a224ad35dd135d47bfa484f337a0769a1128f55c07c65e3af1d5377432da22220aae827b56233bafd024a629300d6aafcbf0996",
      "name": "SYK",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SYK, pmod(Ph))",
      "function": "Protein",
      "id": "1b5a31fffa7b55b4a61e5b5f615f4646cd2dc618533401e83fd8253f8691a84e923d2d45aded1db9fc7e77b3b13cda697798d72271a30a47281e5bac5e8a060b",
      "name": "SYK",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt)",
      "function": "Protein",
      "id": "7d94454106658b1e4190b417a419f7ccbab4b525157cd679cbb4da8a006b08c3819b0a360b692358b3f80ea2648890248be2aa7c97e1d59962dc6aa097560f2d",
      "name": "Mapt",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:hyperphosphorylation))",
      "function": "Protein",
      "id": "b34e093998180b3976865dd766b707451ab8ccfd6e4531877897de1fc1686be19e449c5d0d32ec8c9f205bde40141e912a0deefcf6aa9e26e496aaeeb2359083",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 202))",
      "function": "Protein",
      "id": "adeb05a2545ed7e47feacb95c1c9c3d4153b6290afd7a4d785a7d4d0c5012f970b0d922f6c7c784bf1eecf40d4db81b2ce754f523a92e217a81d7ca1fac5c970",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, var(\"p.Pro301Ser\"))",
      "function": "Protein",
      "id": "9aca426c24191c19664524cdec5e8fa5dbf98d688d380de681fe4bf020304b2a8326c7206d5dc47ec78caadb8fa600f122bfa6c6e7c79ee12f50b056a9bfff34",
      "name": "Mapt",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": "p.Pro301Ser",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(MGI:Syk)",
      "function": "Protein",
      "id": "bd11ebc1899f947ee537c7e9479799678cf93c6a28389f65a0e380baa84a0e3a8891d8189c60971f436ddc998000edcfea30556bec8b12eb0e9ed062518dc7aa",
      "name": "Syk",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Syk, pmod(Ph))",
      "function": "Protein",
      "id": "8b80046791f916c59dc52f5965dd41e265211dc1289b118e44e95c73ba43a7a7798a443b11bae6fc92662657d5b4972e4d6a3ce0cb18b720636969da31157016",
      "name": "Syk",
      "namespace": "MGI",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Syk, pmod(Ph, Tyr, 525))",
      "function": "Protein",
      "id": "97efeaad2cfa9e4b9932ac86d2c3901190f392eec0b2ef3822e3bf0b2168880ec1367b5f3fba75b536d66c6c35e64dd991b593bf7498cafc06a36c1d335b1720",
      "name": "Syk",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 525
        }
      ]
    },
    {
      "bel": "p(MGI:Syk, pmod(Ph, Tyr, 526))",
      "function": "Protein",
      "id": "003e0d2786c3c738d3e8ef5c2039665cac4788e32d324e22368d6ad021b96d01d619df758c7b1a48c85ede9e8217548153cf102efe26120032a62b26daf64817",
      "name": "Syk",
      "namespace": "MGI",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 526
        }
      ]
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "r(HGNC:MAPT)",
      "function": "RNA",
      "id": "54fd242f396c4644b46548885bfbc0e1c22320972c8b0b6c3008a5a1d9152f5a5287d81a693f85e739f039db27862a857420216fe3eb25d300f63e68d47cdad3",
      "name": "MAPT",
      "namespace": "HGNC"
    }
  ]
}